M51I (p.Met51Ile) variant of ADD1 (Alpha-adducin)

M51I (p.Met51Ile) in ADD1 (Alpha-adducin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.45 / 1. The record also includes population frequency data and structural context.

M51I (p.Met51Ile) variant details